Health

Disclosing Gluten in Food

Disclosing Gluten in Food

Pending federal legislation would improve food information for consumers with gluten sensitivity.

Value-Pricing Prescription Drugs

Value-Pricing Prescription Drugs

Scholar argues that reducing pricing for prescription drugs may increase innovation.

Addressing the Dangers of Forever Chemicals

Addressing the Dangers of Forever Chemicals

Experts discuss regulatory options for PFAS chemical contamination control.

Paid Family Leave Is No Child’s Play

Paid Family Leave Is No Child’s Play

Experts examine the benefits and complexities of a paid family leave mandate in the United States.

Addressing the Medical Device Safety Crisis

Addressing the Medical Device Safety Crisis

Scholar calls on FDA to prioritize public health by reforming medical device regulation.

Federal Agencies Enroll Health Insurers in PrEP School

Federal Agencies Enroll Health Insurers in PrEP School

Recent federal guidance clarifies health care coverage on vital HIV medication.

Pennsylvania Lawmakers Restrict Access to Fentanyl Test Strips

Pennsylvania Lawmakers Restrict Access to Fentanyl Test Strips

Pennsylvania law prevents people who use drugs from testing for fentanyl and avoiding overdoses.

How Will Health Care Regulators Address Artificial Intelligence?

How Will Health Care Regulators Address Artificial Intelligence?

Policymakers around the world are developing guidelines for use of artificial intelligence in health care.

The Culture of Antibiotics Regulation

The Culture of Antibiotics Regulation

Scholars discuss the challenges of promoting antibiotic development and preserving existing drugs.

Cracking the Egg Donation Market

Cracking the Egg Donation Market

The booming U.S. egg donation industry requires more regulation to safeguard donor welfare.

Pet Food Regulations May Be More Bark Than Bite

Pet Food Regulations May Be More Bark Than Bite

Regulators strive to keep our animal companions’ food safe, but gaps remain.

Medical AI Regulators Should Learn from the Global Financial Crisis

Medical AI Regulators Should Learn from the Global Financial Crisis

In regulating AI in medicine, FDA should exercise care in implementing a principles-based framework.